What about those who use antiplatelet agents?
Patients who have undergone heart attack, or who have been inserted the stent (s) in a narrow coronary arteries, using the so-called antiplatelet agents to prevent the heart's arteries are blocked again. It deals with acetylsalicylic acid (ASA, ex. Albyl-E) and / or clopidogrel (e.g. Plavix). ASA is a life-long treatment should never be stopped.
The disadvantage of antiplatelet agents is that they increase the risk of bleeding during surgery. Research has shown that the risk of bleeding is clearly lower than the risk of blockage of the coronary artery and the development of heart attack or even death.
Therefore, treatment with these agents continued even if you are going to operate. The exception may be operations in the brain or inside the eye.
Alerts: If you want to know more fresh update helpful articles enter your email address below and be notified by mail.
